Download
s11095-020-2783-4.pdf 1,19MB
WeightNameValue
1000 Titel
  • Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer Nanoparticles
1000 Autor/in
  1. Maslanka Figueroa, Sara |
  2. Fleischmann, Daniel |
  3. Beck, Sebastian |
  4. Goepferich, Achim |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-02-24
1000 Erschienen in
1000 Quellenangabe
  • 37(3):59
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11095-020-2783-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040083/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!Evaluate fundamental parameters that dictate the effectiveness of drug loading.!##!Methods!#!A model water-soluble drug lacking ionizable groups, pirfenidone (PFD), was encapsulated through nanoprecipitation in poly(ethylene glycol)-poly(lactic acid) (PEG-PLA)-poly(lactic-co-glycolic acid) (PLGA) NPs. Firstly, the thermodynamic parameters predicting drug-polymer miscibility were determined to assess the system's suitability. Then, the encapsulation was evaluated experimentally by two different techniques, bulk and microfluidic (MF) nanoprecipitation. Additionally, the number of molecules that fit in a particle core were calculated and the loading determined experimentally for different core sizes. Lastly, the effect of co-encapsulation of α-lipoic acid (LA), a drug with complementary therapeutic effects and enhanced lipophilicity, was evaluated.!##!Results!#!The thermodynamic miscibility parameters predicted a good suitability of the selected system. MF manufacturing enhanced the encapsulation efficiency by 60-90% and achieved a 2-fold higher NP cellular uptake. Considering spatial constrictions for drug encapsulation and increasing the size of the PLGA core the number of PFD molecules per NP was raised from under 500 to up to 2000. More so, the co-encapsulation of LA increased the number of drug molecules per particle by 96%, with no interference with the release profile.!##!Conclusions!#!Thermodynamic, spatial and methodological parameters should be considered to optimize drug encapsulation.
1000 Sacherschließung
lokal encapsulation
lokal Pyridones/chemistry [MeSH]
lokal Polyethylene Glycols/chemistry [MeSH]
lokal Antineoplastic Agents/administration
lokal Lactic Acid/chemistry [MeSH]
lokal Nanocapsules/chemistry [MeSH]
lokal Thermodynamics [MeSH]
lokal Pyridones/administration
lokal nanoprecipitation
lokal Lactic Acid/administration
lokal Research Paper
lokal polymeric nanoparticles
lokal Polylactic Acid-Polyglycolic Acid Copolymer/analogs
lokal microfluidics
lokal Drug Liberation [MeSH]
lokal pirfenidone
lokal Antineoplastic Agents/chemistry [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TWFzbGFua2EgRmlndWVyb2EsIFNhcmE=|https://frl.publisso.de/adhoc/uri/RmxlaXNjaG1hbm4sIERhbmllbA==|https://frl.publisso.de/adhoc/uri/QmVjaywgU2ViYXN0aWFu|https://orcid.org/0000-0002-7646-0252
1000 Hinweis
  • DeepGreen-ID: decb0e4d24e242f5a709cafc904f2309 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6466476.rdf
1000 Erstellt am 2023-11-16T23:36:49.729+0100
1000 Erstellt von 322
1000 beschreibt frl:6466476
1000 Zuletzt bearbeitet 2023-12-01T04:20:46.372+0100
1000 Objekt bearb. Fri Dec 01 04:20:46 CET 2023
1000 Vgl. frl:6466476
1000 Oai Id
  1. oai:frl.publisso.de:frl:6466476 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source